Wang Jie Jin is a professor of epidemiology and the deputy director of the Centre for Clinician-Scientist Development (CCSD) at the Duke-NUS Medical School. Prior to this position she was an associate professor (2007-2011) and professor (2012-2018) at the University of Sydney, a Senior Research Fellow of National Health and Medical Research Council (NHMRC), Australia (2005-2015 inclusive) and an associate professor at the University of Melbourne (2006-2013). She obtained a Masters and a PhD degrees in epidemiology from University of Sydney and a Masters degree in Applied Statistics from Macquarie University, Sydney.

Jie Jin has conducted epidemiological research in visual impairment and the two common causes of visual impairment in older people: age-related macular degeneration (AMD) and age-related cataract. She has been a key investigator of the Blue Mountains Eye Study, a population-based cohort study over 15 years. She expanded many projects using this cohort in collaboration with international researchers in a number of consortia. She led a clinic-based cohort study of 2000 cataract surgical patients to clarify a long-term debate over the possible adverse effect of cataract surgery on AMD risk. Jie Jin and her team documented the associations of visual impairment with poor survival, and correction of visual impairment with better survival among older people in two independent cohorts. She leads investigation of joint contribution of modifiable factors and genetic susceptibility to the risk of AMD and age-related cataract.

Jie Jin was the primary supervisor of 9 PhD and 4 Masters candidates enrolled in the University of Sydney or University of Melbourne, and all 13 candidates had their degrees awarded. She was an associate supervisor of additional 13 PhD and 2 Masters candidates with degrees awarded. Jie Jin is a co-author of 616 original research reports, 19 reviews and 6 book chapters. Jie Jin was a member of Australian NHMRC Project Grant Review Panels from 2011 to 2014 consecutively. She served as the Editor-in-Chief of Ophthalmic Epidemiology from 2011 to 2016.

Jie Jin’s position in Duke-NUS is to provide grantsmanship guidance and support to SGH clinicians to win national funding for their pursuing clinician-scientist careers. Over 3 years since her joining Duke-NUS (2017 to 2019 inclusive), Jie Jin and the CCSD team, together with Duke-NUS senior researchers as workshop mentors, supervised 17 CSA-INV applicants (15 first CSA applicants) and 16 TA applicants within the grantsmanship program, ACE-in-Grants. Of those, 12 CSA applicants, 9 TA applicants were successfully awarded, and 7 submitted in November 2019 with outcome pending.